Answers are grounded in this paper and cite their sources.
I am almost certainly the only surgeon ever to design a new operation that was to be used in both of my own eyes some 40 years later. —Sir Harold Ridley Since the invention of intraocular lenses (IOLs) by Harold Ridley, there has been continuous and significant progress in their manufacture. Apple et al. have classified the development of IOLs into 6 generations (Figure 1).1–3 Although the description of each generation was primarily based on mode or site of fixation, each step forward represented an advance in surgical technique, as well as IOL quality, design, and material. This editorial provides a brief overview of each IOL generation, highlighting complications associated with them. The data included are derived in part from pathological analyses of cadaver eyes and explanted lenses, with some of the longest clinicopathological correlation reports, to our knowledge, involving obsolete IOL designs.Figure 1.: Posterior view of the anterior segment (Miyake-Apple view) of human eyes obtained postmortem implanted with different IOLs. The generation of each lens is indicated in the corresponding photograph. The 3 eyes shown at the bottom are from the “capsular surgery era.” Panel A reprinted with permission from Apple DJ, Sims J. Harold Ridley and the invention of the intraocular lens. Surv Ophthalmol 1996;40:279-292. Panel B reprinted with permission from Yeh O, Werner L, Letocha CE, Mamalis N. Long-term follow-up of obsolete design: iris-clip glass intraocular lens. J Cataract Refract Surg 2008; 34:520-522.Generation I is represented by the Ridley lens itself, which was manufactured by Rayner. It was a biconvex poly(methylmethacrylate) disc designed for implantation in the posterior chamber after extracapsular capsular extraction (ECCE) (Figure 1, A). The first implantation was performed as a 2-step procedure (ECCE in November 1949; IOL implantation in February 1950). The 2 major problems with this lens design were represented by posterior capsule opacification and IOL decentration, this latter due to the excessive weight of the implant, the lack of fixation haptic elements, and performance of irregular anterior capsulotomies at the time.1–3 Owing to the complications with Ridley lenses, Generation II was represented by early anterior chamber IOLs implanted after intracapsular cataract extraction, with most activity between 1952 and 1962.1–3 The initial lenses had excessive anterior vaulting of the entire lens body causing contact with the corneal endothelium. Several modifications led to designs such as the 3-point fixation Strampelli lens and the 4-point fixation Choyce Mark VIII, with significantly less anterior vaulting. However, the corneal problems were still important. We analyzed an enucleated eye, which was blind and painful from a 66-year-old patient implanted with a Choyce Mark lens, as a secondary procedure in 1978.4 The eye developed glaucoma, with implantation of an Ahmed valve in 2006. Histopathological analyses showed corneal decompensation and vascularization, peripheral anterior and posterior synechiae, iris thinning, significant changes in the iris pigment epithelium, and fibrous tissue on the anterior surface of the iris, as well as severe attenuation of the nerve fiber layer and cupping of the disc. The IOL surface was overall smooth and regular, without warping of the footplates, but was covered by clumps of different cell elements, including giant cells intermixed with pigment, which indicates active inflammation. Generation III, with most activity between 1953 and 1973, was represented by iris-fixated IOLs, which were designed to fixate the lens further posteriorly from the cornea.1–3 Different iris-fixated designs were available at the time, including lenses with 2 and 4 loops. Physical contact of IOL haptics with uveal tissue still often caused inflammation and its sequelae, including corneal decompensation, cystoid macular edema, and inflammatory membrane formation. An enucleated human eye was obtained postmortem in our laboratory from a 95-year-old donor who had a 4-loop, iris-clip glass IOL implanted 22 years earlier (Figure 1, B). The patient had a history of mild corneal edema, glaucoma, macular degeneration, and macular pucker. Ultrasound biomicroscopy showed a well-centered iris-fixated IOL. Pathology showed fragments of iris tissue attached to the haptics, pigment dispersion within the eye, signs of corneal decompensation, and significant changes in the iris pigment epithelium.5 Lenses made of glass were discontinued because they may crack during Nd:YAG laser application.6 Binkhorst later modified his early 4-loop iris-clip lens, creating the 2-loop iridocapsular lens, so the optical component remained in front of the iris but the haptics were inserted into the capsular bag after ECCE, which had largely been abandoned as a surgical technique since Ridley first implant.1–3 We evaluated an enucleated postmortem eye from an 86-year-old donor with a 2-loop iridocapsular lens implanted 30 years earlier.7 Although the IOL was relatively well-centered in the eye and the overall design and fixation were associated with some degree of stability, long-term biologic consequences such as corneal decompensation and pigment dispersion were observed because the loops still kept direct contact with the iris in some areas. Generation IV represents a move back to the anterior chamber, with most activity between 1963 and 1992.1–3 The lenses with closed loops fixated into the anterior chamber angle were associated with significant inflammation secondary to a “cheese cutter” effect. Flexible anterior chamber IOLs with open loops and Choyce-style footplates formed the basis for the modern successful open loop anterior chamber IOLs used today. A fibrous scar or callus usually forms at the site of touch between the footplates and the anterior chamber angle recess, protecting adjacent vascular tissues.8 In the early 1980s, the concept of a universal IOL also appeared. The design had overall characteristics of a posterior chamber lens but was to be fixated in the anterior chamber, ciliary sulcus, or capsular bag. However, different studies showed that it is not a good idea to implant a posterior chamber lens into the anterior chamber, and we could confirm that by analyzing a cadaver eye implanted with a Pannu universal IOL for 20 years.9 Histopathological findings of that eye showed signs of corneal decompensation, glaucoma, and chronic inflammation.10 Generation V (circa 1977 to 1987) was characterized by a general lack of modern surgical techniques, as well as malfixation of haptics of the early posterior chamber IOLs. Most fixation of these lenses throughout Generation V was uveal or asymmetric (Figure 1, C). Complications such as IOL decentration and uveal tissue chafing with uveitis–glaucoma–hyphema (UGH) syndrome were common.1–3 Successful transition toward symmetric in-the-bag fixation defines the transition from Generation V or the precapsular surgery era, to Generation VI or the capsular surgery era.1–3 Generation VI-a (circa 1987 to 1992) was the period when high-quality capsular surgery using mostly rigid lenses inserted through large incisions was common (Figure 1, D). Generation VI-b (circa 1992 to present) is the era of small-incision phacoemulsification surgery with implantation of foldable IOL designs, evolving to the modern lenses available today (Figure 1, E and F). However, UGH syndrome can also be observed with modern lenses when the design is not appropriate for the fixation site. Pathologic findings in a cadaver eye study were more severe in eyes implanted with 3-piece foldable IOLs with square anterior optic edges, showing that IOLs with round anterior edges are more suitable for sulcus fixation.11 Single-piece lenses with thick haptics and square and unpolished sidewalls are also not appropriate for the sulcus. A pathological study showed that the side with the haptic fixated in the sulcus exhibited disruption of the iris pigment epithelium.12 Since the creation of our journal, studies on IOLs have been prominently featured in each issue. Indeed, the current issue includes different studies on IOL power calculation and IOL implantation in the setting of congenital cataracts, as well as on toric and presbyopia-correcting IOLs. We are all, in the ophthalmic community, grateful to Sir Harold Ridley for providing us with such an effective “cure” for a condition named aphakia and cannot imagine our specialty today without IOLs. As we celebrate 75 years of the first cataract surgery with IOL implantation, this editorial honors him and helps us understand the pathway to the excellent procedure that is available today.
No takes yet. Share an insight, caveat, or question.
Liliana Pacini Werner (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: